- Home
- OCGN vs EM Comparison
OCGN vs EM Comparison
Compare OCGN & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- EM
- Stock Information
- Founded
- OCGN 2013
- EM 2017
- Country
- OCGN United States
- EM China
- Employees
- OCGN N/A
- EM N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- EM Other Consumer Services
- Sector
- OCGN Health Care
- EM Consumer Discretionary
- Exchange
- OCGN Nasdaq
- EM Nasdaq
- Market Cap
- OCGN 283.3M
- EM 286.5M
- IPO Year
- OCGN N/A
- EM 2021
- Fundamental
- Price
- OCGN $1.03
- EM $1.35
- Analyst Decision
- OCGN Strong Buy
- EM Hold
- Analyst Count
- OCGN 3
- EM 1
- Target Price
- OCGN $6.00
- EM $1.25
- AVG Volume (30 Days)
- OCGN 1.8M
- EM 1.9M
- Earning Date
- OCGN 08-01-2025
- EM 09-19-2025
- Dividend Yield
- OCGN N/A
- EM N/A
- EPS Growth
- OCGN N/A
- EM N/A
- EPS
- OCGN N/A
- EM N/A
- Revenue
- OCGN $4,754,000.00
- EM $259,541,587.00
- Revenue This Year
- OCGN N/A
- EM $3.30
- Revenue Next Year
- OCGN N/A
- EM $5.26
- P/E Ratio
- OCGN N/A
- EM N/A
- Revenue Growth
- OCGN N/A
- EM N/A
- 52 Week Low
- OCGN $0.52
- EM $0.50
- 52 Week High
- OCGN $1.29
- EM $1.45
- Technical
- Relative Strength Index (RSI)
- OCGN 50.51
- EM 68.69
- Support Level
- OCGN $1.00
- EM $1.13
- Resistance Level
- OCGN $1.05
- EM $1.39
- Average True Range (ATR)
- OCGN 0.04
- EM 0.06
- MACD
- OCGN 0.00
- EM 0.01
- Stochastic Oscillator
- OCGN 55.56
- EM 52.38
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.